Wake Forest University Health Sciences: Depressive Disorder trials

The registry lists 14 Depressive Disorder studies with Wake Forest University Health Sciences as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 3 1Phase 4 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and SafetyCompletedNCT05110014Not applicableResults posted
• Use of a Digitally Enabled App With Clinical Team Interface in the Management of DepressionCompletedNCT04891224Not applicableResults posted
• Telephone-Based Intervention to Treat Depression and Anxiety in Hispanic Cancer SurvivorsCompletedNCT04430335Not applicableResults posted
• EMR Outcomes: Anxiety and Depression in EpilepsyCompletedNCT03879525Not applicableResults posted
• Anxiety and Depression in Epilepsy: A Treatment StudyCompletedNCT03464383Phase 4Results posted
• OSA Screen Negative With Spinal DuramorphTerminatedNCT03151226Not applicableResults posted
• The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless AdultsCompletedNCT02732561Not applicableResults posted
• Improving Sleep and Psychological Functioning in People With Depression and InsomniaCompletedNCT00247624Phase 4Results posted
• Computational Psychiatric Approach to DepressionCompletedNCT04189939
• Volunteering as an Intervention to Reduce Depression Among AdolescentsCompletedNCT03816215Not applicable
• Anxiety and Depression in Epilepsy: A Pilot Treatment StudyWithdrawnNCT03522987Phase 4
• Patient Management of Depression Through Technology: a Study of Digitally Enabled EngagementCompletedNCT03242213Not applicable
• Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity DisorderCompletedNCT01430767
• Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating DepressionCompletedNCT00066859Phase 3